US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist

1.280
+0.040+3.23%

Close Jul 12 16:00 ET

1.320
+0.040+3.13%

Post 19:54 ET

327.12MMarket Cap-1763P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

14.30%-31.95M

0.63%-140.88M

-818.71%-14.68M

6.23%-45.16M

-6.09%-43.76M

31.47%-37.28M

-1,421.36%-141.77M

-98.48%2.04M

-6.55%-48.16M

-31.13%-41.25M

Net income from continuing operations

-4,781.76%-48.5M

31.18%-113.87M

-63.82%-47.92M

-10.09%-45.6M

51.96%-21.39M

102.06%1.04M

-4.66%-165.46M

24.73%-29.25M

2.31%-41.42M

-13.96%-44.52M

Operating gains losses

-45.83%305K

108.12%198K

-911.11%-511K

113.87%332K

-236.76%-186K

330.74%563K

-551.48%-2.44M

-91.63%63K

-4,531.48%-2.39M

108.97%136K

Depreciation and amortization

53.39%2.83M

61.98%9.84M

99.79%2.87M

93.96%2.89M

43.81%2.23M

15.67%1.85M

-7.49%6.08M

-35.68%1.44M

2.54%1.49M

7.55%1.55M

Other non cash items

-114.18%-19K

-2,781.62%-21.88M

-268.63%-86K

-268.89%-304K

-6,024.93%-21.63M

-39.09%134K

-30.43%816K

104.78%51K

-78.52%180K

257.84%365K

Change In working capital

124.29%10.36M

-1,529.78%-24.95M

11.17%28.28M

54.01%-4.7M

-31.77%-5.89M

-246.97%-42.65M

-101.14%-1.53M

-84.57%25.44M

10.25%-10.21M

-698.66%-4.47M

-Change in receivables

324.11%15.62M

86.84%-1.29M

-102.92%-582K

61.05%-2.68M

85.90%-1.71M

134.23%3.68M

49.31%-9.81M

60.35%19.97M

33.54%-6.88M

-17.83%-12.14M

-Change in payables and accrued expense

-36,528.57%-7.65M

-306.15%-9.09M

88.00%-1.3M

-56.17%1.01M

-173.92%-8.82M

-97.82%21K

4.78%4.41M

-350.05%-10.79M

398.19%2.3M

28.82%11.93M

-Change in other working capital

105.15%2.39M

-476.20%-14.57M

85.43%30.15M

46.29%-3.02M

209.11%4.65M

-1,756.35%-46.35M

-97.41%3.87M

-89.02%16.26M

-2,152.00%-5.63M

-338.85%-4.26M

Cash from discontinued investing activities

Operating cash flow

14.30%-31.95M

0.63%-140.88M

-818.71%-14.68M

6.23%-45.16M

-6.09%-43.76M

31.47%-37.28M

-1,421.36%-141.77M

-98.48%2.04M

-6.55%-48.16M

-31.13%-41.25M

Investing cash flow

Cash flow from continuing investing activities

-100.74%-358K

98.05%176.54M

225.49%68.2M

98.63%57.31M

-93.89%2.69M

1,112.38%48.34M

17.59%89.14M

173.54%20.95M

-17.22%28.85M

-7.49%44.11M

Net PPE purchase and sale

95.66%-102K

84.13%-4.68M

75.78%-827K

97.11%-289K

86.43%-1.22M

66.98%-2.35M

-244.02%-29.5M

14.97%-3.42M

-512.42%-10.01M

-405.64%-8.96M

Net intangibles purchase and sale

-47.98%-256K

18.44%-199K

--0

---26K

---173K

-17.87%-244K

50.00%-13K

-507.89%-231K

--0

Net business purchase and sale

----

--45.26M

--0

----

--0

----

Net investment purchase and sale

--0

13.59%135.03M

182.25%68.81M

46.38%57.22M

-178.89%-41.87M

2,074.56%50.86M

40.55%118.88M

199.72%24.38M

7.03%39.09M

7.30%53.07M

Net other investing changes

----

--1.12M

--211K

--376K

----

Cash from discontinued investing activities

Investing cash flow

-100.74%-358K

98.05%176.54M

225.49%68.2M

98.63%57.31M

-93.89%2.69M

1,112.38%48.34M

17.59%89.14M

173.54%20.95M

-17.22%28.85M

-7.49%44.11M

Financing cash flow

Cash flow from continuing financing activities

14,815.82%29.24M

-93.16%880K

-94.73%74K

-58.95%596K

-99.86%14K

460.00%196K

291.33%12.87M

2,598.08%1.4M

944.60%1.45M

289.27%9.98M

Net common stock issuance

15,411.17%29.16M

-95.13%624K

-99.93%1K

-69.92%435K

--0

--188K

406.80%12.82M

--1.4M

14,360.00%1.45M

--9.98M

Proceeds from stock option exercised by employees

825.00%74K

412.00%256K

812.50%73K

2,583.33%161K

1,300.00%14K

-77.14%8K

-93.41%50K

-84.62%8K

-95.35%6K

-97.73%1K

Cash from discontinued financing activities

Financing cash flow

14,815.82%29.24M

-93.16%880K

-94.73%74K

-58.95%596K

-99.86%14K

460.00%196K

291.33%12.87M

2,598.08%1.4M

944.60%1.45M

289.27%9.98M

Net cash flow

Beginning cash position

34.14%147.02M

-27.73%109.6M

15.31%93.07M

-19.42%80.2M

33.08%121.44M

-27.73%109.6M

146.68%151.67M

80.83%80.71M

80.67%99.52M

146.40%91.26M

Current changes in cash

-127.31%-3.07M

191.88%36.54M

119.68%53.6M

171.37%12.74M

-419.86%-41.05M

119.03%11.25M

-144.27%-39.77M

-76.87%24.4M

-74.89%-17.86M

-31.66%12.84M

Effect of exchange rate changes

-170.75%-416K

138.15%877K

-92.21%350K

113.51%129K

95.84%-190K

146.30%588K

-729.86%-2.3M

191.31%4.49M

-297.92%-955K

-522.92%-4.57M

End cash Position

18.18%143.53M

34.14%147.02M

15.31%93.07M

-19.42%80.2M

33.08%121.44M

-27.73%109.6M

80.83%80.71M

80.67%99.52M

Free cash flow

18.83%-32.31M

15.01%-145.76M

-1,018.54%-15.5M

22.17%-45.45M

10.37%-45M

35.29%-39.81M

-8,904.36%-171.51M

-101.07%-1.39M

-24.59%-58.4M

-51.05%-50.21M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	14.30%-31.95M	0.63%-140.88M	-818.71%-14.68M	6.23%-45.16M	-6.09%-43.76M	31.47%-37.28M	-1,421.36%-141.77M	-98.48%2.04M	-6.55%-48.16M	-31.13%-41.25M
Net income from continuing operations	-4,781.76%-48.5M	31.18%-113.87M	-63.82%-47.92M	-10.09%-45.6M	51.96%-21.39M	102.06%1.04M	-4.66%-165.46M	24.73%-29.25M	2.31%-41.42M	-13.96%-44.52M
Operating gains losses	-45.83%305K	108.12%198K	-911.11%-511K	113.87%332K	-236.76%-186K	330.74%563K	-551.48%-2.44M	-91.63%63K	-4,531.48%-2.39M	108.97%136K
Depreciation and amortization	53.39%2.83M	61.98%9.84M	99.79%2.87M	93.96%2.89M	43.81%2.23M	15.67%1.85M	-7.49%6.08M	-35.68%1.44M	2.54%1.49M	7.55%1.55M
Other non cash items	-114.18%-19K	-2,781.62%-21.88M	-268.63%-86K	-268.89%-304K	-6,024.93%-21.63M	-39.09%134K	-30.43%816K	104.78%51K	-78.52%180K	257.84%365K
Change In working capital	124.29%10.36M	-1,529.78%-24.95M	11.17%28.28M	54.01%-4.7M	-31.77%-5.89M	-246.97%-42.65M	-101.14%-1.53M	-84.57%25.44M	10.25%-10.21M	-698.66%-4.47M
-Change in receivables	324.11%15.62M	86.84%-1.29M	-102.92%-582K	61.05%-2.68M	85.90%-1.71M	134.23%3.68M	49.31%-9.81M	60.35%19.97M	33.54%-6.88M	-17.83%-12.14M
-Change in payables and accrued expense	-36,528.57%-7.65M	-306.15%-9.09M	88.00%-1.3M	-56.17%1.01M	-173.92%-8.82M	-97.82%21K	4.78%4.41M	-350.05%-10.79M	398.19%2.3M	28.82%11.93M
-Change in other working capital	105.15%2.39M	-476.20%-14.57M	85.43%30.15M	46.29%-3.02M	209.11%4.65M	-1,756.35%-46.35M	-97.41%3.87M	-89.02%16.26M	-2,152.00%-5.63M	-338.85%-4.26M
Cash from discontinued investing activities
Operating cash flow	14.30%-31.95M	0.63%-140.88M	-818.71%-14.68M	6.23%-45.16M	-6.09%-43.76M	31.47%-37.28M	-1,421.36%-141.77M	-98.48%2.04M	-6.55%-48.16M	-31.13%-41.25M
Investing cash flow
Cash flow from continuing investing activities	-100.74%-358K	98.05%176.54M	225.49%68.2M	98.63%57.31M	-93.89%2.69M	1,112.38%48.34M	17.59%89.14M	173.54%20.95M	-17.22%28.85M	-7.49%44.11M
Net PPE purchase and sale	95.66%-102K	84.13%-4.68M	75.78%-827K	97.11%-289K	86.43%-1.22M	66.98%-2.35M	-244.02%-29.5M	14.97%-3.42M	-512.42%-10.01M	-405.64%-8.96M
Net intangibles purchase and sale	-47.98%-256K	18.44%-199K	--0	--0	---26K	---173K	-17.87%-244K	50.00%-13K	-507.89%-231K	--0
Net business purchase and sale	----	--45.26M	--0	--0	----	----	--0	--0	--0	----
Net investment purchase and sale	--0	13.59%135.03M	182.25%68.81M	46.38%57.22M	-178.89%-41.87M	2,074.56%50.86M	40.55%118.88M	199.72%24.38M	7.03%39.09M	7.30%53.07M
Net other investing changes	----	--1.12M	--211K	--376K	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-100.74%-358K	98.05%176.54M	225.49%68.2M	98.63%57.31M	-93.89%2.69M	1,112.38%48.34M	17.59%89.14M	173.54%20.95M	-17.22%28.85M	-7.49%44.11M
Financing cash flow
Cash flow from continuing financing activities	14,815.82%29.24M	-93.16%880K	-94.73%74K	-58.95%596K	-99.86%14K	460.00%196K	291.33%12.87M	2,598.08%1.4M	944.60%1.45M	289.27%9.98M
Net common stock issuance	15,411.17%29.16M	-95.13%624K	-99.93%1K	-69.92%435K	--0	--188K	406.80%12.82M	--1.4M	14,360.00%1.45M	--9.98M
Proceeds from stock option exercised by employees	825.00%74K	412.00%256K	812.50%73K	2,583.33%161K	1,300.00%14K	-77.14%8K	-93.41%50K	-84.62%8K	-95.35%6K	-97.73%1K
Cash from discontinued financing activities
Financing cash flow	14,815.82%29.24M	-93.16%880K	-94.73%74K	-58.95%596K	-99.86%14K	460.00%196K	291.33%12.87M	2,598.08%1.4M	944.60%1.45M	289.27%9.98M
Net cash flow
Beginning cash position	34.14%147.02M	-27.73%109.6M	15.31%93.07M	-19.42%80.2M	33.08%121.44M	-27.73%109.6M	146.68%151.67M	80.83%80.71M	80.67%99.52M	146.40%91.26M
Current changes in cash	-127.31%-3.07M	191.88%36.54M	119.68%53.6M	171.37%12.74M	-419.86%-41.05M	119.03%11.25M	-144.27%-39.77M	-76.87%24.4M	-74.89%-17.86M	-31.66%12.84M
Effect of exchange rate changes	-170.75%-416K	138.15%877K	-92.21%350K	113.51%129K	95.84%-190K	146.30%588K	-729.86%-2.3M	191.31%4.49M	-297.92%-955K	-522.92%-4.57M
End cash Position	18.18%143.53M	34.14%147.02M	34.14%147.02M	15.31%93.07M	-19.42%80.2M	33.08%121.44M	-27.73%109.6M	-27.73%109.6M	80.83%80.71M	80.67%99.52M
Free cash flow	18.83%-32.31M	15.01%-145.76M	-1,018.54%-15.5M	22.17%-45.45M	10.37%-45M	35.29%-39.81M	-8,904.36%-171.51M	-101.07%-1.39M	-24.59%-58.4M	-51.05%-50.21M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall